Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Verastem, Inc. publishes a filing, an earnings call transcript or a press release.

Get VSTM alerts

About Robert Gagnon

Robert Gagnon is recorded as Board Member at Verastem, Inc. (VSTM) since December 13, 2022. Verastem, Inc. reported in an 8-K filed December 15, 2022 that Robert Gagnon was appointed Class II director, effective December 13, 2022. The proxy statement of Verastem, Inc. reports total compensation of $1,597,295 for Robert Gagnon in fiscal 2019, including a base salary of $396,365. Disclosed compensation is on record for 2 fiscal years. Verastem, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Verastem, Inc. includes Brian M. Stuglik (CEO), Daniel Paterson (CEO and Board Member), Michael Bailey (CEO) and 7 others.

“On December 13, 2022, the board of directors of Verastem, Inc. (the "Company") unanimously voted to elect Robert Gagnon as a Class II director of the Company, effective December 13, 2022.”
Verastem, Inc. Form 8-K, filed December 15, 2022 · Read the filing

Affiliation history

Company network

Current role

Biotechnology · Healthcare

Board Member

2022-12-13–present

Leadership on record at Verastem, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2019 Verastem, Inc. (VSTM) $396,365 $1,597,295
2018 Verastem, Inc. (VSTM) $115,462 $3,043,276

Recent activity